Dr Amit Gupta

I am a Consultant Clinical Oncologist working in a tertiary cancer centre, specialising in the treatment of head and neck, base of skull, and skin cancers. I am committed to delivering personalised, evidence-based care with a strong focus on achieving the best possible outcomes while maintaining quality of life for my patients.

I practise at Mount Vernon Cancer Centre, HCA Healthcare UK and Proton International London, in partnership with University College London Hospitals NHS Foundation Trust. Working within these leading centres allows me to offer patients access to advanced technologies and multidisciplinary expertise in complex cancer care.

My areas of clinical expertise include the management of cancers of the head and neck region, base of skull tumours, and skin malignancies. I provide a comprehensive range of advanced radiotherapy techniques, including:

• Intensity-Modulated Radiotherapy (IMRT)
• Proton Beam Radiotherapy
• Superficial Radiotherapy
• Stereotactic Radiotherapy

At Proton International London, I treat patients with head and neck and base of skull cancers using proton beam therapy, an advanced form of radiotherapy designed to precisely target tumours while minimising radiation to surrounding healthy tissue. This highly specialised approach can reduce treatment-related side effects and is particularly valuable for complex tumours located near critical structures.

Alongside my clinical work, I hold academic qualifications and have published research in the field of head and neck oncology. I am actively involved in clinical research and trials, contributing to the development of innovative treatments and improvements in patient care. I also play an active role in medical education and service development, supporting the training of future specialists and continuously enhancing the quality and safety of oncology services.

My practice is centred on compassionate, patient-focused care. I believe in clear communication, shared decision-making, and supporting patients and their families throughout every stage of their treatment journey.